Stocosil's Convertible Note - II Round

Stocosil raised a round of funding on April 01, 2016.

Stocosil is a development stage pharmaceutical company focused on the research, development, and commercialization of the next generation of products for the treatment of high blood pressure (hyperten…

Articles about Stocosil's Convertible Note - II Round: